Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Thyroid Cancer, Papillary 15Neuroendocrine Tumors 14Carcinoma, Neuroendocrine 9Pituitary Neoplasms 8Thyroid Neoplasms 6Pheochromocytoma 6Thyroid Carcinoma, Anaplastic 4Paraganglioma 4Neoplasms 4Multiple Endocrine Neoplasia Type 1 3Recurrence 2Rectal Neuroendocrine Tumor 2Neoplasm Metastasis 2Melanoma 2Cushing Syndrome 2Adenocarcinoma, Follicular 2Acromegaly 2Uterine Cervical Neoplasms 1Urinary Tract Infections 1Thyroid cancer, medullary 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Serotonin Syndrome 1Sarcoma 1SDH-Related Familial Paraganglioma 1Rectal Neuroendocrine Tumors 1Rectal Neoplasms 1Prostatitis 1Prostatic Neoplasms 1Pituitary Diseases 1

Interventions

Endoscopic Mucosal Resection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Rectal Neuroendocrine Tumors × Endocrine × Clear all
NCT07373015 2026-01-28

Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase NA Not yet recruiting
118 enrolled
EndocrineGastrointestinalNET

Rectal Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡